The emerging role of B cells in immune-mediated demyelinating diseases: mechanisms and therapeutic implications
Role of B Cells in Demyelination B cells play a pivotal role in the pathology of demyelinating diseases, such as […]
When the Disc Strikes: Rethinking Fibrocartilaginous Embolism
Understanding Fibrocartilaginous Embolism Fibrocartilaginous embolism is a condition marked by the sudden obstruction of blood vessels due to small fragments
When the Disc Strikes: Rethinking Fibrocartilaginous Embolism Read Post »
Autoimmune nodopathies: a clinical review
Autoimmune Nodopathies Defined Autoimmune nodopathies are a diverse group of disorders characterized by the formation of nodular lesions due to
Autoimmune nodopathies: a clinical review Read Post »
The emerging role of B cells in immune-mediated demyelinating diseases: mechanisms and therapeutic implications
Role of B Cells in Demyelination B cells, a type of lymphocyte found in the immune system, play increasingly recognized
Tumefactive demyelinating disorders as neoplasm mimics: description of a typical case and literature review
Study Overview The exploration of tumefactive demyelinating disorders reveals these conditions as compelling mimics of neoplastic processes, often leading to
Ocrelizumab-induced colitis acutely managed with ciclosporin
Ocrelizumab and Colitis Risk Ocrelizumab is a monoclonal antibody primarily utilized in the treatment of multiple sclerosis (MS) and certain
Ocrelizumab-induced colitis acutely managed with ciclosporin Read Post »
Effectiveness and Safety of Plasmapheresis in MOGAD Attacks: A Systematic Review and Meta-Analysis
Plasmapheresis Mechanism in MOGAD Plasmapheresis, also known as therapeutic plasma exchange, involves the removal and replacement of a patient’s plasma,
Tumefactive demyelinating disorders as neoplasm mimics: description of a typical case and literature review
Study Overview This study investigates the phenomenon of tumefactive demyelinating disorders, which can often masquerade as neoplasms on imaging studies.
Anti-CD20 B cell depletion is associated with elevated mucosal-originating circulating regulatory IgA B cells in multiple sclerosis
Study Overview This study aimed to investigate the relationship between anti-CD20 B cell depletion therapies and the presence of circulating
Ocrelizumab-induced colitis acutely managed with ciclosporin
Background and Rationale Ocrelizumab is a monoclonal antibody approved for the treatment of primary progressive multiple sclerosis (PPMS) and relapsing
Ocrelizumab-induced colitis acutely managed with ciclosporin Read Post »